Veterinary Medicine Information website

Cardio ReVet RV 4 - Injektionslösung für Tiere

Authorised
  • APIS MELLIFICA C12
  • Apocynum cannabinum C12
  • Digitalis purpurea C12
  • Prunus laurocerasus C12
  • Strychnos nux-vomica C12
  • Urginea maritima C12
Download as PDF

Product identification

Medicine name:
Cardio ReVet RV 4 - Injektionslösung für Tiere
Active substance:
  • APIS MELLIFICA C12
  • Apocynum cannabinum C12
  • Digitalis purpurea C12
  • Prunus laurocerasus C12
  • Strychnos nux-vomica C12
  • Urginea maritima C12
Target species:
  • Reptile
  • Ornamental bird
  • Dog
  • Cat
  • Rabbit
  • Ferret
  • Small rodents
Route of administration:
  • Intramuscular use
  • Intravenous use
  • Subcutaneous use

Product details

Active substance and strength:
  • APIS MELLIFICA C12
    1.67
    gram(s)
    /
    10.00
    millilitre(s)
  • Apocynum cannabinum C12
    1.67
    gram(s)
    /
    10.00
    millilitre(s)
  • Digitalis purpurea C12
    1.67
    gram(s)
    /
    10.00
    millilitre(s)
  • Prunus laurocerasus C12
    1.67
    gram(s)
    /
    10.00
    millilitre(s)
  • Strychnos nux-vomica C12
    1.67
    gram(s)
    /
    10.00
    millilitre(s)
  • Urginea maritima C12
    1.67
    gram(s)
    /
    10.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Rabbit
      • Meat and offal
        0
        day
  • Intravenous use
    • Rabbit
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Rabbit
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QV03AX
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Austria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Homeopathic medicinal products (Article 19 of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Pharmazeutische Fabrik Dr. Reckeweg & Co. GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Pharmazeutische Fabrik Dr. Reckeweg & Co. GmbH
Responsible authority:
  • Austrian Agency For Health And Food Safety
Authorisation number:
  • 8-30101
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 26/11/2020
Updated on: 23/04/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 26/11/2020
Updated on: 23/04/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 26/11/2020
Updated on: 23/04/2025
Download

at-puar-600000091422-np-caerdioe-de.pdf

German (PDF)
Published on: 23/04/2025
Download